Ischemic ventricular arrhythmias: Experimental models and their clinical relevance

Heart Rhythm

Volumn 8, Issue 12, 2011, Pages 1963-1968

  Di Diego, José M ^a   Antzelevitch, Charles ^a  

^a MASONIC MEDICAL RESEARCH LABORATORY   (United States)

Author keywords

Acute myocardial infarction; Electrophysiology; Ischemia; Sudden cardiac death; Ventricular fibrillation

Indexed keywords

ACUTE HEART INFARCTION; BIOCHEMISTRY; HEART ELECTROPHYSIOLOGY; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; ISCHEMIC VENTRICULAR ARRHYTHMIA; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 82455171846     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2011.06.036     Document Type: Article

References (36)

1. J.R. de Groot, and R. Coronel Acute ischemia-induced gap junctional uncoupling and arrhythmogenesis Cardiovasc Res 62 2004 323 334
2. N. Luqman, R.J. Sung, C.L. Wang, and C.T. Kuo Myocardial ischemia and ventricular fibrillation: pathophysiology and clinical implications Int J Cardiol 119 2007 283 290
3. E.N. Prystowsky Primary prevention of sudden cardiac death: the time of your life Circulation 109 2004 1073 1075
4. D.P. Zipes, A.J. Camm, and M. Borggrefe ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 2006 e385 e484
5. B. Rodriguez, N. Trayanova, and D. Noble Modeling cardiac ischemia Ann N Y Acad Sci 1080 2006 395 414
6. J.E. Saffitz The pathology of sudden cardiac death in patients with ischemic heart diseasearrhythmology for anatomic pathologists Cardiovasc Pathol 14 2005 195 203
7. J.G. Akar, and F.G. Akar Regulation of ion channels and arrhythmias in the ischemic heart J Electrocardiol 40 2007 S37 S41
8. B.M. Tice, B. Rodriguez, J. Eason, and N. Trayanova Mechanistic investigation into the arrhythmogenic role of transmural heterogeneities in regional ischaemia phase 1A Europace 9 2007 vi46 vi58
9. C.L. Del Rio, P.I. McConnell, and M. Kukielka Electrotonic remodeling following myocardial infarction in dogs susceptible and resistant to sudden cardiac death J Appl Physiol 104 2008 386 393
10. 2+exchanger confers protection against ischemia/reperfusion injury Circ Res 97 2005 916 921
11. B. Rodriguez, B.M. Tice, and J.C. Eason Effect of acute global ischemia on the upper limit of vulnerability: a simulation study Am J Physiol Heart Circ Physiol 286 2004 H2078 H2088
12. B. Rodriguez, B.M. Tice, J.C. Eason, F. Aguel, and N. Trayanova Cardiac vulnerability to electric shocks during phase 1A of acute global ischemia Heart Rhythm 1 2004 695 703
13. G.X. Yan, A. Joshi, and D. Guo Phase 2 reentry as a trigger to initiate ventricular fibrillation during early acute myocardial ischemia Circulation 110 2004 1036 1041
14. M.J. Curtis Characterisation, utilisation and clinical relevance of isolated perfused heart models of ischaemia-induced ventricular fibrillation Cardiovasc Res 39 1998 194 215
15. E. Carmeliet Cardiac ionic currents and acute ischemia: from channels to arrhythmias Physiol Rev 79 1999 917 1017
16. W.E. Cascio, H. Yang, B.J. Muller-Borer, and T.A. Johnson Ischemia-induced arrhythmia: the role of connexins, gap junctions, and attendant changes in impulse propagation J Electrocardiol 38 2005 55 59
17. H. Clements-Jewery, D.J. Hearse, and M.J. Curtis Phase 2 ventricular arrhythmias in acute myocardial infarction: a neglected target for therapeutic antiarrhythmic drug development and for safety pharmacology evaluation Br J Pharmacol 145 2005 551 564
18. P.L. Friedman, J.R. Stewart, J.J. Fenoglio, and A.L. Wit Survival of subendocardial Purkinje fibers after extensive myocardial infarction in dogs: in vitro and in vivo correlations Circ Res 33 1973 597 611
19. R. Lazzara, N. El-Sherif, and B.J. Scherlag Electrophysiological properties of canine Purkinje cells in one-day-old myocardial infarction Circ Res 33 1973 722 734
20. + reveals that ischaemic arrhythmias are caused by independent effects of endogenous "mediators" facilitated by interactions, and moderated by paradoxical antagonism Br J Pharmacol 142 2004 352 366
21. A. Vleugels, J. Vereecke, and E. Carmeliet Ionic currents during hypoxia in voltage-clamped cat ventricular muscle Circ Res 47 1980 501 508
22. G. Isenberg, J. Vereecke, G. Van der Heyden, and E. Carmeliet The shortening of the action potential by DNP in guinea pig ventricular myocytes is mediated by an increase of the time-independent K conductance Pflugers Arch 397 1983 251 259
23. M. Rubart, and D.P. Zipes Mechanisms of sudden cardiac death J Clin Invest 115 2005 2305 2315
24. Z.F. Issa, J. Rosenberger, W.J. Groh, J.M. Miller, and D.P. Zipes Ischemic ventricular arrhythmias during heart failure: a canine model to replicate clinical events Heart Rhythm 2 2005 979 983
25. R. Vidavalur, S. Swarnakar, M. Thirunavukkarasu, S.M. Samuel, and N. Maulik Ex vivo and in vivo approaches to study mechanisms of cardioprotection targeting ischemia/reperfusion (i/r) injury: useful techniques for cardiovascular drug discovery Curr Drug Discov Technol 5 2008 269 278
26. R. Coronel, F.J. Wilms-Schopman, T. Opthof, and M.J. Janse Dispersion of repolarization and arrhythmogenesis Heart Rhythm 6 2009 537 543
27. C.L. Stables, and M.J. Curtis Development and characterization of a mouse in vitro model of ischaemia-induced ventricular fibrillation Cardiovasc Res 83 2009 397 404
28. T. Takahashi, D.P. van, and J.C. Lopshire Optical mapping of the functional reentrant circuit of ventricular tachycardia in acute myocardial infarction Heart Rhythm 1 2004 451 459
29. 2+ exchange blockers in the treatment of cardiac disease Expert Opin Investig Drugs 13 2004 653 664
30. 2+ load attributable to the predominance of forward mode block Circ Res 102 2008 1398 1405
31. A.K. Dhalla, W.Q. Wang, and J. Dow Ranolazine, an antianginal agent, markedly reduces ventricular arrhythmias induced by ischemia and ischemiareperfusion Am J Physiol Heart Circ Physiol 297 2009 H1923 H1929
32. A. Zaza, L. Belardinelli, and J.C. Shryock Pathophysiology and pharmacology of the cardiac "late sodium current." Pharmacol Ther 119 2008 326 339
33. T. Nieminen, D.Y. Nanbu, and I.P. Datti Antifibrillatory effect of ranolazine during severe coronary stenosis in the intact porcine model Heart Rhythm 8 2011 608 614
34. to and action potential notch are smaller in left vs. right canine ventricular epicardium Am J Physiol 271 1996 H548 H561
35. D. Hu, S. Viskin, and A. Oliva Novel mutation in the SCN5A gene associated with arrhythmic storm development during acute myocardial infarction Heart Rhythm 4 2007 1072 1080
36. L. Crotti, D. Hu, and R. Insolia KCNH2-K897T polymorphism increases the risk of life-threatening arrhythmias following acute myocardial infarction Heart Rhythm 7 2010 1720